Product Images Imatinib Mesylate

Imatinib Mesylate is a medicine that comes in the form of a tablet, with each containing 400 mg of imatinib free base. It is manufactured by Hras and BluePoint Laboratories in India under the product name OncoPoint. The usual dosage can be found in the package insert. It is advised to keep the medicine in a tightly sealed container and stored in a cool, dry place between 15°-30°C (59°-86°F). The product's National Drug Code (NDC) is 68001-491-04, and it comes in a pack of 30 tablets.*

This is a medication manufactured by Sun Pharmaceutical Industries Ltd. Each tablet contains 100mg of Imatinib Mesylate. It is dispensed in a USP controlled room and should be kept in a tight container. The recommended dosage can be found in the package insert. The drug should be kept away from children.*

This is a statistical report on clinical trial data comparing the progression of patients on Imatinib Mesylate arm and patients on 1FN+Ara-C arm. The report shows the number of patients with progression and those censored at discontinuation or last follow-up. It also shows a Hazard Ratio of 0.378 with a 95% Confidence Interval of 0.291 and 0.493 and a Log-rank Test P value of less than 0.0001. The last column shows the duration in months since randomization.*

This is a statistical analysis of patients treated with Imatinib Mesylate with or without FN+Ara-C for progression to AP or BC. The table shows the number of patients, with progression and those censored, along with the calculated hazard ratio and Log-rank test results. The study analyzes patients over time, measured in months since randomization.*